These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29144161)

  • 1. Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.
    Mains JR; Donskov F; Pedersen EM; Madsen HHT; Thygesen J; Thorup K; Rasmussen F
    Br J Radiol; 2018 Feb; 91(1082):20160795. PubMed ID: 29144161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma.
    Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
    Invest Radiol; 2017 Feb; 52(2):103-110. PubMed ID: 27513367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of DCE-CT-derived blood volume and flow compared to core biopsy microvessel density in patients with metastatic renal cell carcinoma.
    Drljevic-Nielsen A; Rasmussen F; Nielsen PS; Stilling C; Thorup K; Mains JR; Madsen HHT; Donskov F
    Eur Radiol Exp; 2021 Jul; 5(1):32. PubMed ID: 34327591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
    Reiner CS; Roessle M; Thiesler T; Eberli D; Klotz E; Frauenfelder T; Sulser T; Moch H; Alkadhi H
    Invest Radiol; 2013 Apr; 48(4):183-91. PubMed ID: 23328912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine Parameters in Triple-Bolus Dual-Energy CT Correlate With Perfusion CT Biomarkers of Angiogenesis in Renal Cell Carcinoma.
    Manoharan D; Netaji A; Das CJ; Sharma S
    AJR Am J Roentgenol; 2020 Apr; 214(4):808-816. PubMed ID: 32069083
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiogenesis of renal cell carcinoma: perfusion CT findings.
    Chen Y; Zhang J; Dai J; Feng X; Lu H; Zhou C
    Abdom Imaging; 2010 Oct; 35(5):622-8. PubMed ID: 19763683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT quantification of effects of thalidomide in patients with metastatic renal cell carcinoma.
    Faria SC; Ng CS; Hess KR; Phongkitkarun S; Szejnfeld J; Daliani D; Charnsangavej C
    AJR Am J Roentgenol; 2007 Aug; 189(2):378-85. PubMed ID: 17646464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon.
    Ng CS; Wang X; Faria SC; Lin E; Charnsangavej C; Tannir NM
    AJR Am J Roentgenol; 2010 Jan; 194(1):166-71. PubMed ID: 20028919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1.
    Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
    Invest Radiol; 2014 Sep; 49(9):601-7. PubMed ID: 24691140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in perfusion CT parameter values with commercial software upgrades: a preliminary report about algorithm consistency and stability.
    Mazzei MA; Squitieri NC; Sani E; Guerrini S; Imbriaco G; Di Lucia D; Guasti A; Mazzei FG; Volterrani L
    Acta Radiol; 2013 Sep; 54(7):805-11. PubMed ID: 23612426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis.
    Reiner CS; Goetti R; Eberli D; Klotz E; Boss A; Pfammatter T; Frauenfelder T; Moch H; Sulser T; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):33-40. PubMed ID: 21730874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma.
    Chen C; Kang Q; Wei Q; Xu B; Ye H; Wang T; Lu Y; Lu J
    Abdom Radiol (NY); 2017 May; 42(5):1464-1471. PubMed ID: 27999886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved flow measurement using microbubble contrast agents and disruption-replenishment: clinical application to tumour monitoring.
    Hudson JM; Williams R; Lloyd B; Atri M; Kim TK; Bjarnason G; Burns PN
    Ultrasound Med Biol; 2011 Aug; 37(8):1210-21. PubMed ID: 21683508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced CT of head and neck tumors: comparison of first-pass and permeability perfusion measurements using two different commercially available tracer kinetics models.
    Bisdas S; Konstantinou G; Surlan-Popovic K; Khoshneviszadeh A; Baghi M; Vogl TJ; Koh TS; Mack MG
    Acad Radiol; 2008 Dec; 15(12):1580-9. PubMed ID: 19000875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib.
    Haider MA; Vosough A; Khalvati F; Kiss A; Ganeshan B; Bjarnason GA
    Cancer Imaging; 2017 Jan; 17(1):4. PubMed ID: 28114978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
    Fournier LS; Oudard S; Thiam R; Trinquart L; Banu E; Medioni J; Balvay D; Chatellier G; Frija G; Cuenod CA
    Radiology; 2010 Aug; 256(2):511-8. PubMed ID: 20551183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival.
    Hötker AM; Karlo CA; Zheng J; Moskowitz CS; Russo P; Hricak H; Akin O
    AJR Am J Roentgenol; 2016 May; 206(5):1023-30. PubMed ID: 26934514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy.
    Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
    AJR Am J Roentgenol; 2010 Jun; 194(6):1470-8. PubMed ID: 20489085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma.
    Wang JH; Min PQ; Wang PJ; Cheng WX; Zhang XH; Wang Y; Zhao XH; Mao XQ
    AJR Am J Roentgenol; 2006 May; 186(5):1423-30. PubMed ID: 16632740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Acquisition Method and Region of Interest Placement on Inter-observer Agreement and Measurement of Tumor Response to Targeted Therapy Using Dynamic Contrast-Enhanced Ultrasound.
    Atri M; Hudson JM; Sinaei M; Williams R; Milot L; Moshonov H; Burns PN; Bjarnason GA
    Ultrasound Med Biol; 2016 Mar; 42(3):763-8. PubMed ID: 26712416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.